Development of Burkholderia mallei and pseudomallei vaccines
Open Access
- 1 January 2013
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 3, 10
Abstract
B. mallei and B. pseudomallei are Gram-negative bacteria that cause glanders and melioidosis, respectively. Inhalational infection with either organism can result in severe and rapidly fatal pneumonia. Inoculation by the oral and cutaneous routes can also produce infection. chronic infection develops after recovery from acute infection with both agents, and control of infection with antibiotics requires prolonged treatment. Symptoms for both meliodosis and glanders are non-specific, making diagnosis difficult. B. pseudomallei can be located in the environment, but in the host, B. mallei and B. psedomallei are intracellular organisms. Thefection results in similar immune responses to both agents. Effective early innate immune responses are critical to controlling the early phase of the infection. Innate immune signaling molecules such as TLR, NOD, MyD88 and pro-inflammatory cytokines such as IFN- and TNF-α play key roles in regulating control of infection. Neutrophils and monocytes are critical cells in the early infection for these microorganisms. Both monocytes and macrophages are necessary for limiting dissemination of B. pseudomallei. In contrast, the role of adaptive immune responses in controlling Burkholderia infection is less well understood. However, T cell responses are critical for vaccine protection from Burkholderia infection. At present, effective vaccines for prevention of glanders or meliodosis have not been developed, although recently progress of Burkholderia vaccines has received renewed attention. This review will summarize current and past approaches to develop Burkholderia mallei and pseudomalllei vaccines, with emphasis on immune mechanisms of protection and the challenges facing the field. At present, immunization with live attenuated bacteria provides the most effective and durable immunity, and it is important therefore to understand the immune correlates of protection induced by live attenuated vaccines.Keywords
This publication has 95 references indexed in Scilit:
- Human Polymorphonuclear Neutrophil Responses to Burkholderia pseudomallei in Healthy and Diabetic SubjectsInfection and Immunity, 2009
- The global distribution of Burkholderia pseudomallei and melioidosis: an updateTransactions of the Royal Society of Tropical Medicine and Hygiene, 2008
- Burkholderia pseudomallei Type III Secretion System Mutants Exhibit Delayed Vacuolar Escape Phenotypes in RAW 264.7 Murine MacrophagesInfection and Immunity, 2008
- Endogenous Interleukin-18 Improves the Early Antimicrobial Host Response in Severe MelioidosisInfection and Immunity, 2007
- Type VI secretion is a major virulence determinant in Burkholderia malleiMolecular Microbiology, 2007
- High-Throughput mRNA Profiling Characterizes the Expression of Inflammatory Molecules in Sepsis Caused by Burkholderia pseudomalleiInfection and Immunity, 2007
- Role of Inducible Nitric Oxide Synthase and NADPH Oxidase in Early Control ofBurkholderia pseudomalleiInfection in MiceInfection and Immunity, 2006
- Immunization with Polyamine Transport Protein PotD Protects Mice against Systemic Infection with Streptococcus pneumoniaeInfection and Immunity, 2006
- Melioidosis: Epidemiology, Pathophysiology, and ManagementClinical Microbiology Reviews, 2005
- Quorum-sensing in Gram-negative bacteriaFEMS Microbiology Reviews, 2001